These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2688595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction.
    Shekhonin BV, Guriev SB, Irgashev SB, Koteliansky VE.
    J Mol Cell Cardiol; 1990 May; 22(5):533-41. PubMed ID: 1696997
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Immunomorphological study of fibronectin and collagen types I, III, IV and V in the myocardium in cardiosclerosis].
    Shekhonin BV, Idel'son GL, Kotelianskiĭ VE, Chernousov MA, Sotnikov AV.
    Arkh Patol; 1986 May; 48(1):24-31. PubMed ID: 3516121
    [Abstract] [Full Text] [Related]

  • 5. [Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].
    Shekhonin BV, Tararak EM, Samokhin GP, Vinogradov DV, Kotelianskiĭ VE.
    Arkh Patol; 1990 May; 52(4):16-21. PubMed ID: 2201275
    [Abstract] [Full Text] [Related]

  • 6. Interaction of fibrinogen/fibrin and fibronectin with collagen.
    Hörmann H, Jilek F.
    Artery; 1980 May; 8(5):482-6. PubMed ID: 7213052
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sequential appearance of fibronectin and collagen in experimental granulation tissue.
    Kurkinen M, Vaheri A, Roberts PJ, Stenman S.
    Lab Invest; 1980 Jul; 43(1):47-51. PubMed ID: 6993786
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of fibronectin isoforms after myocardial infarction in rats.
    Ulrich MM, Janssen AM, Daemen MJ, Rappaport L, Samuel JL, Contard F, Smits JF, Cleutjens JP.
    J Mol Cell Cardiol; 1997 Sep; 29(9):2533-43. PubMed ID: 9299376
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tenascin and fibronectin expression in healing human myocardial scars.
    Willems IE, Arends JW, Daemen MJ.
    J Pathol; 1996 Jul; 179(3):321-5. PubMed ID: 8774490
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for the nonmuscle nature of the "myofibroblast" of granulation tissue and hypertropic scar. An immunofluorescence study.
    Eddy RJ, Petro JA, Tomasek JJ.
    Am J Pathol; 1988 Feb; 130(2):252-60. PubMed ID: 3277440
    [Abstract] [Full Text] [Related]

  • 15. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium.
    Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):654-60. PubMed ID: 15358036
    [Abstract] [Full Text] [Related]

  • 16. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells.
    Colvin RB, Gardner PI, Roblin RO, Verderber EL, Lanigan JM, Mosesson MW.
    Lab Invest; 1979 Nov 04; 41(5):464-73. PubMed ID: 228117
    [No Abstract] [Full Text] [Related]

  • 17. Expression of perlecan proteoglycan in the infarct zone of mouse myocardial infarction.
    Nakahama M, Murakami T, Kusachi S, Naito I, Takeda K, Ohnishi H, Komatsubara I, Oka T, Ninomiya Y, Tsuji T.
    J Mol Cell Cardiol; 2000 Jun 04; 32(6):1087-100. PubMed ID: 10888260
    [Abstract] [Full Text] [Related]

  • 18. Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis.
    Shekhonin BV, Tararak EM, Samokhin GP, Mitkevich OV, Mazurov AV, Vinogradov DV, Vlasik TN, Kalantarov GF, Koteliansky VE.
    Atherosclerosis; 1990 Jun 04; 82(3):213-26. PubMed ID: 2198029
    [Abstract] [Full Text] [Related]

  • 19. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D, Liu W, Ao Q, Wang G.
    Med Hypotheses; 2008 Sep 04; 71(3):374-8. PubMed ID: 18565684
    [Abstract] [Full Text] [Related]

  • 20. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness.
    Bergijk EC, Baelde HJ, de Heer E, Killen PD, Bruijn JA.
    Exp Nephrol; 1995 Sep 04; 3(6):338-47. PubMed ID: 8528678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.